Differential Effects of Two Hexahydropyrroloindole Carbamate-Based Anticholinesterase Drugs on the Amyloid Beta Protein Pathway Involved in Alzheimer Disease

Author：  

Publisher： Humana Press, Inc

ISSN： 1535-1084

Source： NeuroMolecular Medicine, Vol.9, Iss.2, 2007-06, pp. : 157-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in the Cellular and Molecular Biology of the Beta-Amyloid Protein in Alzheimer's Disease

By Sambamurti K.   Greig N.H.   Lahiri D.K.  

NeuroMolecular Medicine, Vol. 1, Iss. 1, 2002-03 ,pp. : 2-32

Humana Press, Inc

Access to resources Recommend Favorite

RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease

By Donahue John   Flaherty Stephanie   Johanson Conrad   Duncan John   Silverberg Gerald   Miller Miles   Tavares Rosemarie   Yang Wentian   Wu Qian   Sabo Edmond   Hovanesian Virginia   Stopa Edward  

Acta Neuropathologica, Vol. 112, Iss. 4, 2006-10 ,pp. : 405-415

Springer Publishing Company

Access to resources Recommend Favorite

Amyloid Beta Protein as a Marker or Risk Factor of Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 4, Iss. 4, 2007-01 ,pp. : 359-363

Bentham Science Publishers

Access to resources Recommend Favorite

Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 12, Iss. 1, 2015-01 ,pp. : 32-46

Bentham Science Publishers

Access to resources Recommend Favorite

Ionic effects of the Alzheimer's disease -amyloid precursor protein and its metabolic fragments

By Fraser S.P.   Suh Y.-H.   Djamgoz M.B.A.  

Trends in Neurosciences, Vol. 20, Iss. 2, 1997-02 ,pp. : 67-72

Elsevier

Access to resources Recommend Favorite